These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 9412209

  • 21. Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.
    Woodfield JC, Van Rij AM, Pettigrew RA, van der Linden A, Bolt D.
    World J Surg; 2005 Jan; 29(1):18-24. PubMed ID: 15599747
    [Abstract] [Full Text] [Related]

  • 22. Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.
    Paladino JA, Eubanks DA, Adelman MH, Schentag JJ.
    J Am Geriatr Soc; 2007 May; 55(5):651-7. PubMed ID: 17493183
    [Abstract] [Full Text] [Related]

  • 23. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K, Kawakita M, Hida S, Higashi Y, Yamauchi T, Yoshida O.
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [Abstract] [Full Text] [Related]

  • 24. A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery.
    Anderson G, Boldiston C, Woods S, O'Brien P.
    Arch Surg; 1996 Jul; 131(7):744-8. PubMed ID: 8678775
    [Abstract] [Full Text] [Related]

  • 25. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
    Regnier B.
    Presse Med; 1989 Oct 11; 18(32):1617-21. PubMed ID: 2530546
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M, Kolle L, Soriano G, Ortiz J, Pamplona J, Novella MT, Villanueva C, Sainz S, Torras J, Balanzó J, Guarner C.
    Am J Gastroenterol; 1998 Dec 11; 93(12):2457-62. PubMed ID: 9860409
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
    Gesser RM, McCarroll K, Teppler H, Woods GL.
    J Antimicrob Chemother; 2003 May 11; 51(5):1253-60. PubMed ID: 12697633
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluating the cost-effectiveness of treatment with third-generation cephalosporins.
    Gladen HE.
    Diagn Microbiol Infect Dis; 1992 Jan 11; 15(1):99-105. PubMed ID: 1730191
    [Abstract] [Full Text] [Related]

  • 32. [Clinical evaluation of ceftizoxime in the treatment of complicated urinary tract infections].
    Takaha M, Ichikawa Y, Sagawa S, Sonoda T, Nakamura T, Kotake T, Miki T, Yano H, Itatani H, Shin T.
    Hinyokika Kiyo; 1984 Oct 11; 30(10):1519-29. PubMed ID: 6098179
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of oral gemifloxacin versus intravenous ceftriaxone followed by oral cefuroxime with/without a macrolide for the treatment of hospitalized patients with community-acquired pneumonia.
    Bhavnani SM, Ambrose PG.
    Diagn Microbiol Infect Dis; 2008 Jan 11; 60(1):59-64. PubMed ID: 17889491
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.